Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients

Overview of attention for article published in BMC Infectious Diseases, September 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Altmetric has seen 9 X posts from 5 X users, with an upper bound of 22,260 followers.

Safety of PLLA (New-Fill) in the Treatment of Facial Lipoatrophy - HIV+ Pts http://t.co/cLH3TKvkyD HT @MurdochUni http://t.co/MAHCRUsooI

Safety of PLLA (New-Fill) in the Treatment of Facial Lipoatrophy - HIV+ Pts http://t.co/cLH3TKvkyD HT @MurdochUni http://t.co/MAHCRUsooI

Safety of PLLA (New-Fill) in the Treatment of Facial Lipoatrophy - HIV+ Pts http://t.co/OeaCvQsje9 HT @MurdochUni http://t.co/dWjG6qtNTi

Safety of PLLA (New-Fill) in the Treatment of Facial Lipoatrophy - HIV+ Pts http://t.co/pzaMlEn7JH HT @MurdochUni http://t.co/rKlF03Opyy

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.